Peer-reviewedCC BYGenes & diseases
Thymidylate synthase expression identifies hepatocellular carcinoma vulnerable to fluoropyrimidine-based therapy
- 1Genomic Medicine Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon 34141, Republic of Korea
- 2Bionanotechnology Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), Daejeon 34141, Republic of Korea
Related
- Wild-type and mutated ß-catenin differently repress RND3/RHOE expression in hepatocellular carcinoma
- Integrated DNA methylation and gene expression analysis identifies CpG biomarkers in breast cancer
- HSP27 Provides Stress-Adaptive Proteostasis Buffering in Glioblastoma and Is Therapeutically Vulnerable
- Complete mitogenome of vulnerable goonch catfish Bagarius bagarius: mitochondrial DNA methylation marks and phylogenetic insights
- MUTYH knockdown suppresses the growth of hepatocellular carcinoma cells and modulates their response to chemotherapy
BibTeX
@article{choi2026thymidylate,
title = {{Thymidylate synthase expression identifies hepatocellular carcinoma vulnerable to fluoropyrimidine-based therapy}},
author = {Hyunji Choi and Yeeun Lee and Juyoung Lee and Jang-Yu Lee and Sangwon Byun and Kyunghee Noh and Kyung Chan Park and Wonbeak Yoo},
journal = {Genes \& diseases},
year = {2026},
month = may,
url = {https://europepmc.org/article/PMC/PMC13742270},
note = {CC BY},
}
RIS
TY - JOUR
TI - Thymidylate synthase expression identifies hepatocellular carcinoma vulnerable to fluoropyrimidine-based therapy
AU - Hyunji Choi
AU - Yeeun Lee
AU - Juyoung Lee
AU - Jang-Yu Lee
AU - Sangwon Byun
AU - Kyunghee Noh
AU - Kyung Chan Park
AU - Wonbeak Yoo
PY - 2026
DA - 2026/05/17
JO - Genes & diseases
UR - https://europepmc.org/article/PMC/PMC13742270
SN - 2352-4820
SN - 2352-3042
ER -